Wednesday, June 30, 2010

Six More Chances

Well, gang. We're halfway through the run of The Little One, which means that time is running out to see Nosedive's vampire epic.

We've been getting some very nice responses to this show, and it's something we here at Nosedive Central are particularly happy with/proud of, and something many folks are enjoying a great deal.

Photo by Daniel Winters

"Mr. Comtois concentrates on the themes of death and decay as well as the relationship challenges posed by immortality in his bloody story. He aims to scare by presenting his vampires with an unsentimental realism that makes them seem almost human, without soft-pedaling the brutality and violence."
—Jason Zinoman, "To Bleed or Not to Bleed? Plays Explore the Scary," The New York Times

Photo by Aaron Epstein

"The Little One has plenty of action, suspense, and more than a little stage blood. More profound and more philosophical than you ever expect 'genre theatre' to be. A compelling new work."
—Martin Denton,'s PICK OF THE WEEK

"Comtois at his inventive best. Like a bloodier Tuck Everlasting. The Little One leaves audiences with more than enough to sink their teeth into."
—Aaron Riccio, That Sounds Cool

Photo by Daniel Winters

"The Little One has a lot to offer lovers of vampire stories and fans of fantasy and horror. Ms. Byers’ performance is one that shouldn’t be missed. Great Geek Theater."
—Teresa Jusino, Pink Raygun

"This two-hour show ends too soon, like a good book that you wanted to keep reading. Beautifully incarnated by the entire bloodthirsty cast, The Little One is a play that kidnaps you from modern day East Village reality and drops you into the vampire’s den with total immersion."
—Lina Zeldovich, The Happiest Medium

Photo by Aaron Epstein

There are only six shows left, and space is starting to fill up quickly.

Don't miss out.

Just lookin out for ya,

James "Concerned Theatre Nanna" Comtois

Labels: , ,


Post a Comment

<< Home

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 2.5 License.